LEYDEN LABS
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The Company’s energetic team of world-renown biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.
LEYDEN LABS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.leydenlabs.com
Total Employee:
11+
Status:
Active
Total Funding:
187.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Current Advisors List
Board_member
2021-03-01
Board_member
2021-03-01
Board_member
Current Employees Featured
Dinko Valerio Co-Founder & Executive Chairman @ Leyden Labs
Co-Founder & Executive Chairman
2020-01-01
Jaap Goudsmit Founder and Chief Scientific Officer @ Leyden Labs
Founder and Chief Scientific Officer
Koenraad Wiedhaup Founder and CEO @ Leyden Labs
Founder and CEO
2021-01-01
Ronald Brus Founder and Chief Business Officer @ Leyden Labs
Founder and Chief Business Officer
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series B - Leyden Labs
Bluebird Ventures
Bluebird Ventures investment in Series B - Leyden Labs
Brook Byers
Brook Byers investment in Series B - Leyden Labs
GV
GV investment in Series B - Leyden Labs
Casdin Capital
Casdin Capital investment in Series B - Leyden Labs
SoftBank Vision Fund
SoftBank Vision Fund investment in Series B - Leyden Labs
Invus
Invus investment in Series B - Leyden Labs
Brook Byers
Brook Byers investment in Series A - Leyden Labs
GV
GV investment in Series A - Leyden Labs
F-Prime Capital
F-Prime Capital investment in Series A - Leyden Labs
Official Site Inspections
http://www.leydenlabs.com Semrush global rank: 5.04 M Semrush visits lastest month: 1.64 K
- Host name: 73.0.153.160.host.secureserver.net
- IP address: 160.153.0.73
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Leyden Labs"
Leyden Labs | Protecting Now From What Comes Next
Our company is developing nasal sprays containing antibodies that target respiratory viruses in the nasal mucosa. These sprays aim to: Stop the initial infection at the gate: which can prevent …See details»
News - Leyden Labs
HollandBIO represents and connects life science companies in the Netherlands and stimulates rapid accessibility of innovation. Over 200 companies are linked through this organization to work towards a better future. Recently, Leyden …See details»
Leyden Labs - Crunchbase Company Profile & Funding
View contacts for Leyden Labs to access new leads and connect with decision-makers. Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and …See details»
Leyden Labs - LinkedIn
Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses.See details»
LL_teamoverview - Leyden Labs
Meet our fantastic team. Together, we work towards our mission of freeing you from viruses.See details»
Leyden Labs - Leiden Bio Science Park
Housing over 215 organisations, including 150 Life Sciences & Health (LSH) companies – from start-ups to multinationals – and several internationally acclaimed research institutes, the …See details»
Leyden Labs, with license from J&J, secures $140M to stop viruses …
Jan 25, 2022 · Pandemic preparedness is a big buzzword these days in public health, and Leyden Labs wants to put the words into action with an intranasal spray to go after coronavirus …See details»
Leyden Labs Raises $200M in 2021 for a New Approach to Combat …
Jan 25, 2022 · Leyden Labs’ platform is built on two innovative concepts: broad protection against known viruses, new variants and newly emerging viruses, and protection at the gate, in the …See details»
Leyden Labs to Unlock a New Generation of Preventative …
Mar 25, 2021 · Funding to advance platform and portfolio of intranasal products that protect against a broad range of respiratory viruses, including influenza and coronaviruses, to let …See details»
Leyden Labs to Unlock a New Generation of …
AMSTERDAM and BOSTON – March 25, 2021 – Leyden Laboratories B.V., (the "Company" or "Leyden Labs") a company targeting commonalities of viral families to protect humanity from known and future viruses, today announced the …See details»
Leyden Labs Company Profile 2024: Valuation, Funding …
Developer of intranasal products designed to free humanity from the burden of respiratory viruses.See details»
Leyden Labs - Craft
See insights on Leyden Labs including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Leyden Labs - VentureRadar
May 14, 2021 · Website: http://www.leydenlabs.com/ Develops innovative nasal sprays delivering antibodies to prevent respiratory infections, offering broad protection against existing and …See details»
Leyden Labs Raises $200M in 2021 for a New Approach to Combat …
AMSTERDAM and BOSTON – January 25, 2022 – Leyden Laboratories B.V., (the "Company" or "Leyden Labs") today announced closing a $140M Series B financing, bringing its total capital …See details»
Leyden Labs Raises $200M in 2021 for a New Approach to
Jan 25, 2022 · Leyden Labs’ platform is built on two innovative concepts: broad protection against known viruses, new variants and newly emerging viruses, and protection at the gate, in the …See details»
Leyden Labs Licenses Pan-Influenza Antibody from Janssen
Jan 18, 2022 · Leyden Labs has entered into an exclusive licensing agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, …See details»
Leyden Labs Raises $200M in 2021 for a New Approach to Combat …
Jan 25, 2022 · --$140M Series B financing led by Casdin Capital and GV (formerly Google Ventures) with participation from leading global life science investors -- -- Proceeds accelerate …See details»
Nanopharm and Leyden Labs Announce Agreement - News
Newport, United Kingdom and Amsterdam, the Netherlands, July 21, 2021 - Nanopharm Ltd., an Aptar Pharma company and leader in contract research and development of orally inhaled and …See details»
Leyden Labs Aims $140 Million More at Severe Respiratory
Jan 25, 2022 · Netherlands-based Leyden Labs secured $140 million in a Series B financing round. Combined with $40 million from a Series A round in March 2021, the company has …See details»
Publications - Leyden Labs
A new study by Leyden Labs, published in Nature’s Scientific Reports, shows that the CR9114 antibody can protect intranasally at low dosages against H5N1 in vivo. SARS‑CoV‑2 elicits …See details»